CompletedNCT04606173
Adjunctive Team Enhanced Intervention to Improve Suicide prevention Evidence-Based Practices in Primary Care
This study has finished and is no longer accepting participants.
In SyracuseSuicidalityInterventional study
Mental health studies with practical context.
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
CompletedNCT00572117
Topiramate for alcohol use in bipolarity
About this title
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
Read the official source — NCT00572117Official study title
Adjunctive Topiramate for Treatment of Alcohol Dependence in Patients With Bipolar Disorder
This study has finished and is no longer accepting participants.
In Palo AltoBipolarityMedication studyAges 18+
CompletedNCT05049460
Adjunctive Transcranial Stimulation to Reduce Impulsivity in Opiate Use Disorder
This study has finished and is no longer accepting participants.
In LexingtonAddictionDevice studyAges 18–60
CompletedNCT00222235
Glycine or D-cycloserine added to antipsychotic treatment for schizophrenia
About this title
Adjunctive Treatment for Decreasing Symptoms of Schizophrenia
Read the official source — NCT00222235Official study title
Cognitive and Negative Symptoms in Schizophrenia Trial (CONSIST)
This study has finished and is no longer accepting participants.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–54
TerminatedNCT02726659
Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression
Official study title
Adjunctive Use of Celecoxib in the Treatment of Bipolar Postpartum Depression: a Randomized, Double-blind, Placebo-controlled Trial
This study ended early.
In LondonBipolarity, DepressionMedication studyAges 18–45
CompletedNCT04898270
Adjunctive Use of Fute (Flupentixol) in Multi-acting Receptor-targeted Antipsychotics Treated Schizophrenia Patients
What is this study about?
This study evaluated the effectiveness of Flupentixol for people with schizophrenia.
This study has finished and is no longer accepting participants.
In TaichungSchizophreniaMedication studyAges 20–65
TerminatedNCT03437668
Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia
This study ended early.
Multiple locations, including Los AngelesSchizophreniaMedication studyAges 18–64
CompletedNCT00483548
Ziprasidone or placebo added to a mood stabilizer for bipolarity depression
About this title
Adjunctive Ziprasidone in the Treatment of Bipolar I Depression
Read the official source — NCT00483548Official study title
A Six-Week, Double-Blind, Multicenter, Placebo Controlled Study Evaluating The Efficacy And Safety Of Flexible Doses Of Oral Ziprasidone As Add-On, Adjunctive Therapy With Lithium, Valproate Or Lamotrigine In Bipolar I Depression
This study has finished and is no longer accepting participants.
Multiple locations, including ChandlerBipolarity, DepressionMedication studyAges 18+
CompletedNCT06372834
Adjuvant Accelerated piTBS for Reducing Suicide prevention in TRD Patients
Official study title
Efficacy of Adjuvant Accelerated Prolonged Intermittent Theta Burst Stimulation for Reducing Suicidal Ideation in Therapy-resistant Depressed Patients: A Randomized, Sham-controlled Trial
This study has finished and is no longer accepting participants.
In TaipeiDepression, SuicidalityDevice studyAges 20–65
CompletedACTRN12618001784202
Adjuvant N Acetylcysteine for Post Traumatuic Stress Disorder
Official study title
N-acetylcysteine as an Adjunctive Treatment in treatment-resistant Post-Traumatic Stress Disorder: a randomised controlled trial
This study has finished and is no longer accepting participants.
Multiple locations, including Heidelberg WestPTSDInterventional studyAges 18+
CompletedNCT02506322
Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolarity
Official study title
Adjuvant Psychotherapy for Relapse Prevention in Early Adulthood (< 35 yr.) of Bipolar Disorder
This study has finished and is no longer accepting participants.
In TübingenBipolarityBehavioural studyAges 18–55
CompletedNCT01066403
Pergolide or placebo and cognitive control in schizophrenia
About this title
Adjuvant Therapy With Pergolide in Treating Cognitive Deficits in Schizophrenia
Read the official source — NCT01066403Official study title
Dopaminergic Modulation of Prefrontal Functions in Schizophrenic Patients: Adjuvant Therapy With Pergolide
This study has finished and is no longer accepting participants.
Multiple locations, including MannheimSchizophreniaMedication studyAges 18–65
Registry coverage
We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.